Mark Cuban invests in dozens of companies, but he’s never put his own name on one before. That changed with Mark Cuban Cost Plus Drug Company. In this conversation, he tells LinkedIn’s Editor-in-Chief, Dan Roth, exactly why he wants to make commonly prescribed prescription drugs available as cheaply as he can, and what industries he thinks up-and-coming entrepreneurs should set their sights on. Follow <a href="https://www.linkedin.com/in/mark-cuban-06a0755b/">Mark Cuban</a> on LinkedInFollow <a href="https://www.linkedin.com/in/danielroth1/">Daniel Roth</a> on LinkedInJoin our This is Working community by subscribing to <a href="https://www.linkedin.com/newsletters/6456608959552905216/">Dan’s newsletter</a> and posting your thoughts using the hashtag #ThisIsWorking.

Kimberly Bryant on what’s next for her and Black Girls CODE

Join LinkedIn’s Editor-in-Chief Dan Roth as he pulls back the curtain on how the world’s most dynamic leaders think, lead, and build. Going beyond titles and buzzwords, This Is Working uncovers the human stories behind high-impact leadership. These are the thoughtleaders and changemakers who are reshaping industries: from tacos to tech, AI to alcohol-free beer, fashion to finance. You’ll hear from guests like Jamie Dimon on rethinking talent, Chuck Robbins on leading through transformation, and Dr. Fei-Fei Li on the human side of AI. Tune in every other week for candid conversations on what’s working at work, and what’s yet to come.